Literature DB >> 27637122

Pulmonary Hypertension: Diagnosis and Treatment.

Beth Dunlap1, George Weyer2.   

Abstract

Pulmonary hypertension is a common, complex group of disorders that result from different pathophysiologic mechanisms but are all defined by a mean pulmonary arterial pressure of 25 mm Hg or greater. Patients often initially present to family physicians; however, because the symptoms are typically nonspecific or easily attributable to comorbid conditions, diagnosis can be challenging and requires a stepwise evaluation. There is limited evidence to support screening of asymptomatic individuals. Echocardiography is recommended as the initial step in the evaluation of patients with suspected pulmonary hypertension. A definitive diagnosis cannot be made on echocardiographic abnormalities alone, and some patients require invasive evaluation by right heart catheterization. For certain categories of pulmonary hypertension, particularly pulmonary arterial hypertension, treatment options are rapidly evolving, and early diagnosis and prompt referral to an expert center are critical to ensure the best prognosis. There are no directed therapies for many other categories of pulmonary hypertension; therefore, family physicians have a central role in managing contributing comorbidities. Other important considerations for patients with pulmonary hypertension include influenza and pneumonia immunizations, contraception counseling, preoperative assessment, and mental health.

Entities:  

Mesh:

Year:  2016        PMID: 27637122

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  11 in total

1.  An association between volumes of the cardiac chambers and troponin levels in individuals submitted to cardiac coronary computed tomography.

Authors:  Zach Rozenbaum; Yaron Arbel; Yoav Granot; Dotan Cohen; Haim Shmilovich; Tomer Ziv-Baran; Ehud Chorin; Ofer Havakuk; Merav Cohen; Shlomo Berliner; Yan Topilsky; Galit Aviram
Journal:  Clin Cardiol       Date:  2017-06-14       Impact factor: 2.882

2.  The clinical characteristics and outcomes of patients with pulmonary hypertension in association with hyperthyroid state: A systematic review.

Authors:  Fateen Ata; Adeel Ahmad Khan; Zohaib Yousaf; Hassan Choudry; Areej Marwan Mohammed; Bilal Ahmed; Ahmed Muaaz Umer; Fareeha Khan; Dabia Hamad Sh Al Mohanadi; Emad Naem; Muhammad Zahid
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

Review 3.  Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Liyan Zhang; Yuping Bai; Peijing Yan; Tingting He; Bin Liu; Shanlian Wu; Zhen Qian; Changtian Li; Yunshan Cao; Min Zhang
Journal:  Heart Fail Rev       Date:  2021-02-05       Impact factor: 4.214

Review 4.  Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension.

Authors:  Zhijie Yu; Jun Xiao; Xiao Chen; Yi Ruan; Yang Chen; Xiaoyuan Zheng; Qiang Wang
Journal:  Chin Med       Date:  2022-01-15       Impact factor: 5.455

5.  A Novel Doppler TRPG/AcT Index Improves Echocardiographic Diagnosis of Pulmonary Hypertension after Pulmonary Embolism.

Authors:  Olga Dzikowska-Diduch; Katarzyna Kurnicka; Barbara Lichodziejewska; Olga Zdończyk; Dominika Dąbrowska; Marek Roik; Szymon Pacho; Maksymilian Bielecki; Piotr Pruszczyk
Journal:  J Clin Med       Date:  2022-02-18       Impact factor: 4.241

Review 6.  A narrative review of research advances in hypoxic pulmonary hypertension.

Authors:  Tianci Chai; Chen Qiu; Zhihong Xian; Yongzhen Lu; Yuwei Zeng; Jie Li
Journal:  Ann Transl Med       Date:  2022-02

7.  Midterm postoperative prognosis of patients with severe left heart valvular disease combined with moderate or severe pulmonary hypertension treated with treprostinil.

Authors:  Ning Xu; Shu-Ting Huang; Kai-Peng Sun; Zeng-Chun Wang; Hua Cao; Qiang Chen
Journal:  BMC Cardiovasc Disord       Date:  2020-11-03       Impact factor: 2.298

8.  Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition.

Authors:  Rui-Xing Wang; Rui-Lan He; Hai-Xia Jiao; Run-Tian Zhang; Jing-Yi Guo; Xiao-Ru Liu; Long-Xin Gui; Mo-Jun Lin; Zhi-Juan Wu
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

9.  Relationship between transesophageal echocardiography-derived pulmonary artery systolic pressure measurements and early morbidity in patients undergoing coronary artery bypass grafting.

Authors:  Hariharan Subramanian; Satyen Parida; Chitra Rajeswari Thangaswamy; Ashok Shankar Badhe; B V Sai Chandran; Sandeep Kumar Mishra
Journal:  Ann Card Anaesth       Date:  2020 Oct-Dec

Review 10.  ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.

Authors:  Tadeu L Montagnoli; Jaqueline S da Silva; Susumu Z Sudo; Aimeé D Santos; Gabriel F Gomide; Mauro P L de Sá; Gisele Zapata-Sudo
Journal:  Cells       Date:  2021-06-30       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.